Literature DB >> 10697221

Application of LCModel for quality control and quantitative in vivo 1H MR spectroscopy by short echo time STEAM sequence.

M Hájek1, M Burian, M Dezortová.   

Abstract

The linear combination of model spectra (LCModel) calculation of a parameter for long-term quality control, kT, was introduced, representing the ratio of the temporal and nominal intensities of CH3 groups of lactate and acetate in a quality control phantom. This procedure is a part of the quality assurance of the scanner using fully automatic measurement and calculation of kT parameters, and utilizing Shewhart regulation control charts for continuous evaluation of the magnetic resonance (MR) scanner setting. The application of the kT parameter for the correction of in vivo data increases the precision of molar concentration determination by about 4%. This was tested by the quantitative in vivo MR determination of the molar concentrations of 13 prominent metabolites (N-acetylaspartate (NAA), N-acetylaspartylglutamate, creatine and phosphocreatine (Cr), choline-containing compounds (Cho), myo-inositol, scyllo-inositol, gamma-aminobutyric acid, glutamine, glutamate, glucose, lactate, alanine, taurine) in the white matter and hippocampus of the brain in groups of volunteers, using a short echo time stimulated echo acquisition mode sequence (echo time = 10 ms) and the LCModel technique. The repeatability of the measurement of prominent metabolites such as NAA, Cr and Cho was found to be around 10% (relative standard deviation, n = 6); precision in a group of volunteers (n = 20 and 28, respectively) was in the range of approximately 13-20%. For other metabolites, which are measured with a lower signal-to-noise ratio, the precision can be much lower.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10697221     DOI: 10.1007/bf02613107

Source DB:  PubMed          Journal:  MAGMA        ISSN: 0968-5243            Impact factor:   2.310


  6 in total

1.  Decreasing choline signal--a marker of phenylketonuria?

Authors:  M Dezortová; L Hejcmanová; M Hájek
Journal:  MAGMA       Date:  1996 Sep-Dec       Impact factor: 2.310

2.  [Results and consequences of frequent quality control of quantitative clinical 1H-MR-spectroscopy].

Authors:  W Roser; W Steinbrich; E W Radue
Journal:  Rofo       Date:  1997-06

3.  Absolute concentrations of metabolites in the adult human brain in vivo: quantification of localized proton MR spectra.

Authors:  T Michaelis; K D Merboldt; H Bruhn; W Hänicke; J Frahm
Journal:  Radiology       Date:  1993-04       Impact factor: 11.105

4.  Development of the human brain: in vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy.

Authors:  R Kreis; T Ernst; B D Ross
Journal:  Magn Reson Med       Date:  1993-10       Impact factor: 4.668

Review 5.  1H MR spectroscopy in patients with mesial temporal epilepsy.

Authors:  M Hájek; M Dezortová; V Komárek
Journal:  MAGMA       Date:  1998-12       Impact factor: 2.310

6.  Estimation of metabolite concentrations from localized in vivo proton NMR spectra.

Authors:  S W Provencher
Journal:  Magn Reson Med       Date:  1993-12       Impact factor: 4.668

  6 in total
  8 in total

1.  The role of relaxation time corrections for the evaluation of long and short echo time 1H MR spectra of the hippocampus by NUMARIS and LCModel techniques.

Authors:  Filip Jírů; Monika Dezortová; Martin Burian; Milan Hájek
Journal:  MAGMA       Date:  2003-10-16       Impact factor: 2.310

2.  MR relaxometry and 1H MR spectroscopy for the determination of iron and metabolite concentrations in PKAN patients.

Authors:  Milan Hájek; Miriam Adamovicová; Vít Herynek; Antonín Skoch; Filip Jírů; Anna Krepelová; Monika Dezortová
Journal:  Eur Radiol       Date:  2004-11-24       Impact factor: 5.315

3.  Investigation of NAA and NAAG dynamics underlying visual stimulation using MEGA-PRESS in a functional MRS experiment.

Authors:  Ricardo C G Landim; Richard A E Edden; Bernd Foerster; Li Min Li; Roberto J M Covolan; Gabriela Castellano
Journal:  Magn Reson Imaging       Date:  2015-12-02       Impact factor: 2.546

4.  1H MR spectroscopy as a diagnostic tool for cerebral creatine deficiency.

Authors:  Monika Dezortova; Filip Jiru; Jan Petrasek; Vera Malinova; Jiri Zeman; Milan Jirsa; Milan Hajek
Journal:  MAGMA       Date:  2008-08-26       Impact factor: 2.310

5.  Realistic head-shaped phantom with brain-mimicking metabolites for 7 T spectroscopy and spectroscopic imaging.

Authors:  Ghil Jona; Edna Furman-Haran; Rita Schmidt
Journal:  NMR Biomed       Date:  2020-10-04       Impact factor: 4.044

6.  NAA and NAAG variation in neuronal activation during visual stimulation.

Authors:  G Castellano; C S B Dias; B Foerster; L M Li; R J M Covolan
Journal:  Braz J Med Biol Res       Date:  2012-08-16       Impact factor: 2.590

7.  Quality Control Procedure Based on Partitioning of NMR Time Series.

Authors:  Michał Staniszewski; Agnieszka Skorupa; Łukasz Boguszewicz; Maria Sokół; Andrzej Polański
Journal:  Sensors (Basel)       Date:  2018-03-06       Impact factor: 3.576

8.  Four-and-one-half years' experience in monitoring of reproducibility of an MR spectroscopy system--application of in vitro results to interpretation of in vivo data.

Authors:  Agnieszka Skorupa; Magdalena Wicher; Tomasz Banasik; Ewa Jamroz; Justyna Paprocka; Aleksandra Kiełtyka; Maria Sokół; Marek Konopka
Journal:  J Appl Clin Med Phys       Date:  2014-05-08       Impact factor: 2.102

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.